Sio Gene Correlations

SIOXDelisted Stock  USD 0.40  0.01  2.56%   
The current 90-days correlation between Sio Gene Therapies and Magenta Therapeutics is 0.16 (i.e., Average diversification). The correlation of Sio Gene is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Sio Gene Correlation With Market

Good diversification

The correlation between Sio Gene Therapies and DJI is -0.17 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Sio Gene Therapies and DJI in the same portfolio, assuming nothing else is changed.
  
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

Moving together with Sio Stock

  0.64DNOW Now IncPairCorr

Moving against Sio Stock

  0.47REKR Rekor Systems Buyout TrendPairCorr
  0.4SGEN Seagen IncPairCorr
  0.37FRSX Foresight AutonomousPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
RZLTASMB
RZLTTIL
TILTCON
RZLTTCON
TILASMB
RZLTNLTX
  
High negative correlations   
NUVBTCON
NUVBMGTA
CTMXMGTA
NUVBTIL
NLTXMGTA
ABIOMGTA

Risk-Adjusted Indicators

There is a big difference between Sio Stock performing well and Sio Gene Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Sio Gene's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
MGTA  2.62  0.16  0.01 (0.21) 3.40 
 5.88 
 16.99 
GNCAQ  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
TCON  6.84 (1.64) 0.00  0.79  0.00 
 19.59 
 52.05 
ABIO  4.85 (1.00) 0.00 (0.31) 0.00 
 6.61 
 123.58 
NLTX  2.25 (0.20) 0.00 (0.68) 0.00 
 4.05 
 27.84 
CTMX  3.64 (0.33) 0.00 (0.16) 0.00 
 7.32 
 23.37 
ASMB  2.86 (0.24) 0.00 (0.22) 0.00 
 5.74 
 24.82 
TIL  5.77 (0.25) 0.00 (0.12) 0.00 
 14.68 
 26.56 
NUVB  3.30  0.10  0.02  0.26  3.70 
 9.48 
 23.46 
RZLT  2.86 (0.09) 0.00 (0.05) 0.00 
 6.80 
 19.56 

View Sio Gene Related Equities

 Risk & Return  Correlation

Still Interested in Sio Gene Therapies?

Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.